ABSTRACT
The Maillard reaction that leads to the formation of advanced glycation end products (AGEs) plays an important role in the pathogenesis of angiopathy in diabetic patients, in aging, and in neurodegenerative processes. We hypothesize that acetaldehyde (AA), one of the main metabolites of alcohol, may be involved in alcohol-induced neurotoxicity in vivo by formation of AA-derived AGEs (AA-AGEs) with brain proteins. Incubation of cortical neurons with AA-AGE produced a dose-dependent increase in neuronal cell-death, and the neurotoxicity of AA-AGE was neutralized by the addition of an anti-AA-AGE-specific antibody, but not by anti-N-ethyllysine (NEL) antibody. The AA-AGE epitope was detected in human brain of alcoholism. We propose that the structural epitope AA-AGE is an important toxic moiety for neuronal cells in alcoholism.
Subject(s)
Acetaldehyde/toxicity , Cerebral Cortex/metabolism , Glycation End Products, Advanced/toxicity , Neurons/drug effects , Acetaldehyde/chemistry , Acetaldehyde/metabolism , Albumins/metabolism , Alcoholism/metabolism , Alcoholism/pathology , Animals , Antibodies/metabolism , Apoptosis/physiology , Cattle , Cells, Cultured , Cerebral Cortex/cytology , Glycation End Products, Advanced/chemistry , Glycation End Products, Advanced/metabolism , Humans , Neurons/cytology , Neurons/metabolism , Rabbits , RatsABSTRACT
Chromatographic separation of an extract of the bulbs of Scilla sibirica resulted in the isolation of five pyrrolidines, two pyrrolidine glycosides, six piperidines, one piperidine glycoside, and eight pyrrolizidines. 2,5-Dideoxy-2,5-imino-glycero-d-manno-heptitol (homoDMDP, 1) is a common alkaloid in all plants of the Hyacinthaceae examined to date and was also found in S. sibirica. The structures of the new alkaloids were elucidated by spectroscopic methods as 7-deoxy-homoDMDP (4), 2,5-dideoxy-2,5-imino-glycero-d-galacto-heptitol (5), the 4-O-beta-d-mannoside (6) and the 4-O-beta-d-mannobioside (7) of 6-deoxy-homoDMDP (2), 7-deoxyhomonojirimycin (12), 7-deoxyhomomannojirimycin (13), and polyhydroxypyrrolizidines, hyacinthacines A(4) (15), A(5) (16), A(6) (17), A(7) (18), B(4) (20), B(5) (21), and B(6) (22). HomoDMDP (1) is a potent inhibitor of beta-glucosidase and beta-galactosidase, while 6-deoxy-homoDMDP (2) showed significantly less inhibition. However, 7-deoxygenation of 1, leading to 4, showed no effect on the inhibitory activity toward both enzymes. Although 2 is not an inhibitor of alpha-l-fucosidase, the monomannoside of 2 shows inhibitory activity toward alpha-l-fucosidase. Elongation of the beta-mannopyranosyl chain of 6 to give 7 enhanced the inhibitory activity.
Subject(s)
Enzyme Inhibitors/isolation & purification , Piperidines/isolation & purification , Plants, Medicinal/chemistry , Pyrrolidines/isolation & purification , Pyrrolizidine Alkaloids/isolation & purification , Scilla/chemistry , Animals , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Galactosidases/antagonists & inhibitors , Glucosidases/antagonists & inhibitors , Hydroxylation , Inhibitory Concentration 50 , Mannosides/antagonists & inhibitors , Molecular Conformation , Molecular Mimicry , Molecular Structure , Netherlands , Nuclear Magnetic Resonance, Biomolecular , Penicillium/enzymology , Piperidines/chemistry , Piperidines/pharmacology , Pyrrolidines/chemistry , Pyrrolidines/pharmacology , Pyrrolizidine Alkaloids/chemistry , Rats , Stereoisomerism , alpha-L-Fucosidase/antagonists & inhibitorsABSTRACT
Chromatographic separation of the pod extract of Angylocalyx pynaertii resulted in the isolation of 13 sugar-mimic alkaloids (1-13). The structures of the new alkaloids were elucidated by spectroscopic methods as the 6-O-beta-D-glucoside (10) and N-hydroxyethyl derivative (11) of 1,4-dideoxy-1,4-imino-D-arabinitol (DAB) (1), 1,6-dideoxynojirimycin (12), and 1,3,4-trideoxynojirimycin (13). 2,5-Imino-1,2,5-trideoxy-L-glucitol (7), 2,5-dideoxy-2,5-imino-D-fucitol (8), and beta-homofuconojirimycin (9), isolated from the pods as well as the bark, were very specific inhibitors of alpha-L-fucosidase with no significant inhibitory activity toward other glycosidases. In this work, 1,4-dideoxy-1,4-imino-D-ribitol (6) was found to be a better inhibitor of lysosomal beta-mannosidase than 2,5-imino-1,2,5-trideoxy-D-mannitol (2). N-Hydroxyethyl-1-deoxynojirimycin (miglitol), which is commercially available for the treatment of diabetes, retained its inhibitory potential toward rat intestinal maltase and sucrase, whereas 11 and the synthetic N-hydroxyethyl derivative of 2,5-dideoxy-2,5-imino-D-mannitol markedly lowered or abolished their inhibition toward all enzymes tested.